CN111787913A - 用于透皮施用包含有机硅丙烯酸杂化聚合物的丁丙诺啡的透皮治疗系统 - Google Patents

用于透皮施用包含有机硅丙烯酸杂化聚合物的丁丙诺啡的透皮治疗系统 Download PDF

Info

Publication number
CN111787913A
CN111787913A CN201980016022.8A CN201980016022A CN111787913A CN 111787913 A CN111787913 A CN 111787913A CN 201980016022 A CN201980016022 A CN 201980016022A CN 111787913 A CN111787913 A CN 111787913A
Authority
CN
China
Prior art keywords
buprenorphine
therapeutic system
transdermal therapeutic
silicone
containing layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980016022.8A
Other languages
English (en)
Chinese (zh)
Inventor
M.埃姆根布罗伊赫
G.沃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of CN111787913A publication Critical patent/CN111787913A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201980016022.8A 2018-03-13 2019-03-11 用于透皮施用包含有机硅丙烯酸杂化聚合物的丁丙诺啡的透皮治疗系统 Pending CN111787913A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161418 2018-03-13
EP18161418.1 2018-03-13
PCT/EP2019/056010 WO2019175096A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system for the transdermal administration of buprenorphine comprising a silicone acrylic hybrid polymer

Publications (1)

Publication Number Publication Date
CN111787913A true CN111787913A (zh) 2020-10-16

Family

ID=61628178

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980016022.8A Pending CN111787913A (zh) 2018-03-13 2019-03-11 用于透皮施用包含有机硅丙烯酸杂化聚合物的丁丙诺啡的透皮治疗系统

Country Status (7)

Country Link
US (1) US20210000755A1 (cg-RX-API-DMAC7.html)
EP (1) EP3764995A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021517569A (cg-RX-API-DMAC7.html)
CN (1) CN111787913A (cg-RX-API-DMAC7.html)
BR (1) BR112020017484A2 (cg-RX-API-DMAC7.html)
CA (1) CA3092750A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019175096A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240374544A1 (en) * 2021-08-30 2024-11-14 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2599847A1 (en) * 2011-11-29 2013-06-05 Dow Corning Corporation A Silicone Acrylate Hybrid Composition and Method of Making Same
CN105007906A (zh) * 2012-12-12 2015-10-28 Lts勒曼治疗系统股份公司 经皮递送系统
CN105377245A (zh) * 2013-06-04 2016-03-02 Lts勒曼治疗系统股份公司 透皮递送系统
WO2016130408A1 (en) * 2015-02-09 2016-08-18 Dow Corning Corporation Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101432698B1 (ko) 2006-06-06 2014-08-22 다우 코닝 코포레이션 실리콘 아크릴레이트 하이브리드 조성물
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
CA2815898C (en) * 2010-11-17 2018-12-18 Hexal Ag Transdermal therapeutic system comprising buprenorphine
EP3349737A4 (en) * 2015-09-14 2019-05-15 Amneal Pharmaceuticals LLC SYSTEM FOR TRANSDERING
WO2018015424A1 (en) * 2016-07-22 2018-01-25 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2599847A1 (en) * 2011-11-29 2013-06-05 Dow Corning Corporation A Silicone Acrylate Hybrid Composition and Method of Making Same
CN105007906A (zh) * 2012-12-12 2015-10-28 Lts勒曼治疗系统股份公司 经皮递送系统
CN105377245A (zh) * 2013-06-04 2016-03-02 Lts勒曼治疗系统股份公司 透皮递送系统
WO2016130408A1 (en) * 2015-02-09 2016-08-18 Dow Corning Corporation Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same

Also Published As

Publication number Publication date
WO2019175096A1 (en) 2019-09-19
US20210000755A1 (en) 2021-01-07
BR112020017484A2 (pt) 2020-12-22
CA3092750A1 (en) 2019-09-19
EP3764995A1 (en) 2021-01-20
JP2021517569A (ja) 2021-07-26

Similar Documents

Publication Publication Date Title
TWI882948B (zh) 用於經皮投予胍法辛(guanfacine)的包含聚矽氧聚合物之經皮治療系統
CN110799180A (zh) 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
US20220241215A1 (en) Transdermal therapeutic system comprising an active agent-containing layer comprising a silicone-containing polymer and a skin contact layer comprising a silicone gel adhesive
CN111867570A (zh) 含尼古丁和有机硅丙烯酸杂化聚合物的透皮治疗系统
EP4395749A1 (en) Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid
CN110809466A (zh) 含东莨菪碱和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
CN112040936B (zh) 用于透皮施用索利那新的透皮治疗系统
CN111867569A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
CN111971032A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JP7641279B2 (ja) フィンゴリモドの経皮投与のための経皮治療システム
CN111971033A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JP2021517569A (ja) シリコーンアクリルハイブリッドポリマーを含む、ブプレノルフィンの経皮投与のための経皮治療システム
HK40043162A (en) Transdermal therapeutic system for the transdermal administration of solifenacin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201016

WD01 Invention patent application deemed withdrawn after publication